trial · primary record
TROP2 CAR/IL-15 TGFBR2 KO NK cells
Squamous Cell Carcinoma
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 36 |
| Primary completion | 2030-06-30 |
| Primary endpoint | Safety and Adverse Events (AEs) |
| Registry ID | NCT07631013 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:53.166Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07631013
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.